Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation

INTRODUCTION: Dexmedetomidine was shown in two European randomized double-blind double-dummy trials (PRODEX and MIDEX) to be non-inferior to propofol and midazolam in maintaining target sedation levels in mechanically ventilated intensive care unit (ICU) patients. Additionally, dexmedetomidine short...

Descripción completa

Detalles Bibliográficos
Autores principales: Turunen, Heidi, Jakob, Stephan M, Ruokonen, Esko, Kaukonen, Kirsi-Maija, Sarapohja, Toni, Apajasalo, Marjo, Takala, Jukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391080/
https://www.ncbi.nlm.nih.gov/pubmed/25887576
http://dx.doi.org/10.1186/s13054-015-0787-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391080/
https://www.ncbi.nlm.nih.gov/pubmed/25887576
http://dx.doi.org/10.1186/s13054-015-0787-y

Ejemplares similares